红花注射液与氢化麦角碱联用治疗老年急性脑梗塞

目的：比较红花注射液与氢化麦角碱联用及常规单用复方丹参注射液治疗老年急性脑梗塞的疗效。方法：62例急性脑梗塞患者随机分为治疗组和对照组，治疗组30例用红花注射液20ml，氢化麦角碱注射液0．6mg分别加入5％葡萄糖注射液250ml静脉滴注，1次／d，对照组32例予复方丹参注射液20ml加入5％葡萄糖溶液250ml静脉滴注，1次／d，两组疗程均为15d，观察两组疗效及治疗组治疗前后血常规，血流动力学各项指标的变化。结果：治疗组总有效率为97％，对照组总效率为81％，治疗组明显优于对照组（P＜0．05），结论：红花注射液与氢化麦角碱注射液合肜治疗老年急性脑梗塞的疗效优于单用丹参注射液。

The Treatment of Acute Cerebral Infarction in the Age by Honghua Injection Combined with Dihydroergotoxine Methanesufonate

Objective:To compare the treatment effect between Honghua injection combined with Dihydroergotoxine Methanesufonate (DM) and routine Dansheng injection on the acute cerebral infarction of the age.Methods:62 cases of acute cerebral infarction were divided into two groups:the treatment group and control group.The treatment group were treated by 20ml of Honghua injection combined with DM in 5% glucose 250ml/i.v.drip.The control group were treated by 20ml of Dansheng injection in 5% glucose 250ml/i.v.drip.The treatment course was 15 days.The treatment effects,the routine blood and the blood flow index were analyzed.Results:The total treatment effect rates in treatment and control group were 97% and 81%,respectively.The effect in treatment group was better than that in control group ( P <0.05).Conclusion:A better effect is obtained when Honghua injection is combined with DM to treat acute cerebral infarction of the age.